XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 28, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Apr 1, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 16.98%2.39B | -14.06%1.07B | 6.30%759M | 93.55%180M | 4,875.00%382M | 12.12%2.04B | -2.20%1.25B | 84.02%714M | 830.00%93M | -8M |
Net income from continuing operations | -7.70%1.58B | 2.51%612M | 21.08%563M | 19.30%445M | -113.62%-38M | 25.38%1.71B | 1.19%597M | 66.07%465M | 62.88%373M | --279M |
Operating gains losses | --585M | ---- | --0 | --0 | 58,600.00%585M | ---- | ---- | ---- | --0 | ---1M |
Depreciation and amortization | -5.62%336M | 2.35%87M | -2.33%84M | -4.60%83M | -15.31%83M | -19.09%356M | -22.02%85M | -20.37%86M | -22.32%87M | --98M |
Other non cash items | -57.89%16M | -86.67%4M | -125.00%-3M | 209.09%12M | -57.14%3M | 65.22%38M | 900.00%30M | 1,100.00%12M | -164.71%-11M | --7M |
Change In working capital | -34.42%-371M | -36.80%304M | -44.90%54M | -3.42%-423M | 31.17%-307M | 16.11%-276M | -8.38%481M | 151.04%98M | -2.76%-409M | ---446M |
-Change in receivables | -36.67%-246M | -380.77%-125M | 60.98%-64M | -0.59%-170M | -36.87%113M | -60.71%-180M | 77.78%-26M | -62.38%-164M | -19.01%-169M | --179M |
-Change in inventory | -69.00%62M | -61.32%41M | -113.79%-8M | -41.94%36M | 73.08%-7M | 182.64%200M | -10.17%106M | 169.88%58M | 153.91%62M | ---26M |
-Change in payables and accrued expense | 309.72%302M | 9.49%427M | -5.07%206M | -12.09%-241M | 83.21%-90M | -131.93%-144M | -38.49%390M | 87.07%217M | -93.69%-215M | ---536M |
-Change in other current assets | -159.76%-213M | 13.79%66M | 13.51%-96M | -645.45%-60M | -207.50%-123M | -8,100.00%-82M | 56.76%58M | -362.50%-111M | 118.03%11M | ---40M |
-Change in other working capital | -294.29%-276M | -123.40%-105M | -83.67%16M | 112.24%12M | -769.57%-200M | 83.53%-70M | 68.03%-47M | 198.00%98M | -416.13%-98M | ---23M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 16.98%2.39B | -14.06%1.07B | 6.30%759M | 93.55%180M | 4,875.00%382M | 12.12%2.04B | -2.20%1.25B | 84.02%714M | 830.00%93M | ---8M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -22.46%-507M | 55.79%-107M | -362.30%-282M | -22.41%-71M | 11.32%-47M | 70.15%-414M | 62.88%-242M | 1.61%-61M | 50.00%-58M | -53M |
Capital expenditure reported | -1.58%-257M | -7.41%-87M | 12.31%-57M | -28.30%-68M | 14.81%-46M | 1.17%-253M | -10.96%-81M | 7.14%-65M | 10.17%-53M | ---54M |
Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net business purchase and sale | -61.11%-290M | 86.90%-22M | -11,200.00%-226M | 16.67%-5M | -825.00%-37M | 84.71%-180M | 71.38%-168M | 89.47%-2M | 89.83%-6M | ---4M |
Net investment purchase and sale | 110.53%40M | -71.43%2M | -83.33%1M | 100.00%2M | 620.00%36M | -58.70%19M | -12.50%7M | -77.78%6M | -50.00%1M | --5M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -22.46%-507M | 55.79%-107M | -362.30%-282M | -22.41%-71M | 11.32%-47M | 70.15%-414M | 62.88%-242M | 1.61%-61M | 50.00%-58M | ---53M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -11.81%-1.45B | 15.48%-213M | -18.60%-491M | 36.89%-231M | -94.68%-512M | -42.94%-1.3B | -24.75%-252M | -195.71%-414M | -2,915.38%-366M | -263M |
Net issuance payments of debt | -61,700.00%-618M | ---- | ---313M | --0 | ---305M | -100.32%-1M | --0 | --0 | -100.32%-1M | --0 |
Net common stock issuance | 75.43%-172M | 53.77%-49M | 95.11%-13M | 69.63%-65M | 61.40%-44M | -2.94%-700M | -55.88%-106M | -3,225.00%-266M | -31.29%-214M | ---114M |
Cash dividends paid | -11.04%-654M | -12.33%-164M | -11.56%-164M | -10.14%-163M | -10.14%-163M | -11.13%-589M | -10.61%-146M | -11.36%-147M | -12.12%-148M | ---148M |
Net other financing activities | 20.00%-4M | ---- | 0.00%-1M | ---- | ---- | 16.67%-5M | --0 | ---1M | ---3M | ---1M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -11.81%-1.45B | 15.48%-213M | -18.60%-491M | 36.89%-231M | -94.68%-512M | -42.94%-1.3B | -24.75%-252M | -195.71%-414M | -2,915.38%-366M | ---263M |
Net cash flow | ||||||||||
Beginning cash position | 28.68%1.71B | 54.29%1.4B | 94.51%1.38B | 47.95%1.51B | 28.68%1.71B | -29.30%1.33B | 10.71%910M | -0.98%710M | 16.40%1.02B | --1.33B |
Current changes in cash | 30.15%436M | -0.13%750M | -105.86%-14M | 63.14%-122M | 45.37%-177M | 171.28%335M | 79.24%751M | 28.49%239M | -255.91%-331M | ---324M |
Effect of exchange rate changes | -186.67%-39M | -218.18%-52M | 194.87%37M | -147.37%-9M | -176.19%-16M | 156.96%45M | -47.62%44M | 51.85%-39M | 127.94%19M | --21M |
End cash Position | 23.28%2.1B | 23.28%2.1B | 54.29%1.4B | 94.51%1.38B | 47.95%1.51B | 28.68%1.71B | 28.68%1.71B | 10.71%910M | -0.98%710M | --1.02B |
Free cash flow | 19.15%2.13B | -15.55%983M | 8.17%702M | 180.00%112M | 641.94%336M | 14.29%1.79B | -3.00%1.16B | 104.09%649M | 181.63%40M | ---62M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |